Oncogenic transcription factors in the human acute leukemias.

Chromosomal translocations in the human acute leukemias rearrange the regulatory and coding regions of a variety of transcription factor genes. The resultant protein products can interfere with regulatory cascades that control the growth, differentiation, and survival of normal blood cell precursors. Support for this interpretation comes from the results of gene manipulation studies in mice, as well as the sequence homology of oncogenic transcription factors with proteins known to regulate embryonic development in primitive organisms, including the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster. Many of these genetic alterations have important prognostic implications that can guide the selection of therapy. The insights gained from studies of translocation-generated oncogenes and their protein products should hasten the development of highly specific, and hence less toxic, forms of leukemia therapy.

[1]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[2]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[3]  Maria Grazia Valsecchi,et al.  Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials , 1997 .

[4]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[5]  Kevin S. Smith,et al.  Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2 , 1997, Oncogene.

[6]  Peter B. Dervan,et al.  Regulation of gene expression by small molecules , 1997, Nature.

[7]  T. Magnuson,et al.  Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond. , 1997, Trends in genetics : TIG.

[8]  J. Downing,et al.  TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Bloomfield,et al.  Clinical significance of cytogenetics in acute myeloid leukemia. , 1997, Seminars in oncology.

[10]  S. Korsmeyer,et al.  HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint , 1997, Nature.

[11]  Mark J Alkema,et al.  Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. , 1997, Genes & development.

[12]  M. Cleary,et al.  The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis , 1997, Molecular and cellular biology.

[13]  U. Thorsteinsdóttir,et al.  Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia , 1997, Molecular and cellular biology.

[14]  U. Thorsteinsdóttir,et al.  Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. , 1997, Immunity.

[15]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[16]  M. Caligiuri,et al.  Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. , 1996, Blood.

[17]  A. Look,et al.  Reversal of apoptosis by the leukaemia-associated E2A–HLF chimaeric transcription factor , 1996, Nature.

[18]  G. Zon,et al.  Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice. , 1996, Blood.

[19]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[20]  Q. Lu,et al.  Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex , 1996, Molecular and cellular biology.

[21]  N. Zeleznik-Le,et al.  Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. , 1996, Blood.

[22]  F. Askari,et al.  Antisense-oligonucleotide therapy. , 1996, The New England journal of medicine.

[23]  Keisuke Toyama,et al.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 , 1996, Nature Genetics.

[24]  Takuro Nakamura,et al.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.

[25]  R. Krumlauf,et al.  Paralogous Hox genes: function and regulation. , 1996, Annual review of genetics.

[26]  S. Korsmeyer,et al.  Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.

[27]  G. Sauvageau,et al.  Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. , 1995, Experimental hematology.

[28]  M. Bienz,et al.  Transcriptional silencing of homeotic genes in drosophila , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[29]  K. Tobal,et al.  Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission , 1995, British journal of haematology.

[30]  M. Sofroniew,et al.  The Hox11 gene is essential for cell survival during spleen development. , 1995, Development.

[31]  J. Cleveland,et al.  c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.

[32]  U. Thorsteinsdóttir,et al.  Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. , 1995, Genes & development.

[33]  C. Murre,et al.  Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2 , 1995, Mechanisms of Development.

[34]  A. Strasser,et al.  Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. , 1995, Current opinion in immunology.

[35]  M. Cleary,et al.  Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. , 1995, Genes & development.

[36]  C. Chastang,et al.  Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group. , 1995, Leukemia & lymphoma.

[37]  Look At.  ONCOGENIC ROLE OF MASTER TRANSCRIPTION FACTORS IN HUMAN LEUKEMIAS AND SARCOMAS : A DEVELOPMENTAL MODEL , 1995 .

[38]  C. Pui.  Medical progress : childhood leukemias , 1995 .

[39]  N. Speck,et al.  A new transcription factor family associated with human leukemias. , 1995, Critical reviews in eukaryotic gene expression.

[40]  J. Rowley,et al.  Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. , 1995, Leukemia.

[41]  E. Dmitrovsky,et al.  A ribozyme which discriminates in vitro between PML/RAR alpha, the t(15;17)-associated fusion RNA of acute promyelocytic leukemia, and PML and RAR alpha, the transcripts from the nonrearranged alleles. , 1994, Cancer research.

[42]  G. Sauvageau,et al.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[44]  R. Krumlauf.  Hox genes in vertebrate development , 1994, Cell.

[45]  S. Korsmeyer,et al.  Hox11 controls the genesis of the spleen , 1994, Nature.

[46]  H. Horvitz,et al.  C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.

[47]  H. Horvitz,et al.  The genetics of programmed cell death in the nematode Caenorhabditis elegans. , 1994, Cold Spring Harbor symposia on quantitative biology.

[48]  F. Mandelli,et al.  Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long- term remission , 1993 .

[49]  E. Wieschaus,et al.  extradenticle, a regulator of homeotic gene activity, is a homolog of the homeobox-containing human proto-oncogene pbx1 , 1993, Cell.

[50]  A. Aronheim,et al.  The E2A gene product contains two separable and functionally distinct transcription activation domains. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Raimondi.  Current Status of Cytogenetic Research in Childhood Acute Lymphoblastic Leukemia , 1993 .

[52]  C. Murre,et al.  A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells , 1993, Molecular and cellular biology.

[53]  C. Largman,et al.  Homeobox Genes in Normal Hematopoiesis and Leukemia , 1992 .

[54]  O. Witte,et al.  Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. , 1992, Science.

[55]  A. Goddard,et al.  Chromosome aberrations and cancer. , 1991, Science.

[56]  E. Dmitrovsky,et al.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.

[57]  A. Perkins,et al.  Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[58]  F. Behm,et al.  Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[60]  J. Rowley,et al.  Recurring chromosome abnormalities in leukemia and lymphoma. , 1990, Seminars in hematology.

[61]  T. Kadesch,et al.  Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. , 1990, Science.

[62]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[63]  J. M. Adams,et al.  Expression of Hox-2.4 homeobox gene directed by proviral insertion in a myeloid leukemia. , 1989, Nucleic acids research.

[64]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[65]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[66]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[67]  G. Ehrlich,et al.  The Metabolic Basis Of Inherited Disease. , 1973 .

[68]  Raymond Scalettar,et al.  The Metabolic Basis of Inherited Disease , 1967 .